• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
CommentaryInflation

Hospital monopolies are buying up independent physicians and hiking prices–but Congress has an opportunity to rein them in

By
Rob Davidson
Rob Davidson
By
Rob Davidson
Rob Davidson
March 7, 2024, 7:12 AM ET
Large hospital systems are buying up independent physicians’ practices. Over half of physicians are now employed by hospitals and health systems.
Large hospital systems are buying up independent physicians’ practices. Over half of physicians are now employed by hospitals and health systems.Getty Images

To anyone who has been forced to cough up an out-of-pocket medical payment, whether it be for a routine procedure or a life-saving operation, it comes as no surprise that this country is facing an epidemic of high health care costs.

What many patients don’t recognize is that it’s not just the cost of drugs, or insurance inaccessibility that’s driving up costs for everyday Americans–it’s also the strategic greed of large hospital systems taking over independent practices, adding up to hundreds of billions of dollars for patients and taxpayers.

Like so many people needing care nationwide, my ER patients in West Michigan are regularly faced with an impossible choice–either pay the high price tag and exorbitant fees demanded by these monopolized hospitals or forfeit the treatment they need. This is especially true in rural areas like mine, where health care consolidation is driving up the cost of care for my patients.

I’ve seen this too often over the last two decades, and it’s heartbreaking to me, not just as their doctor but as someone who has taken an oath to alleviate suffering. Some patients have told me that they stopped getting critical and potentially lifesaving tests because they just don’t know whether they’ll get slapped with hundreds, even thousands, of dollars in hospital fees. Often, their conditions worsen, becoming more emergent and more painful. They wind up in my emergency department for issues that could have been prevented.

As other doctors across the country know, these types of stories are becoming increasingly common in health care. And they’re costing all of our patients dearly.

Procedures as routine as an ultrasound can cost twice as much depending on where you go–to an independent physician’s practice office, which are becoming few and far between, or to a “hospital outpatient clinic”–administered by the same type of medical professional. 

Here’s what’s happening: Large hospital systems are buying up independent physicians’ practices–in fact, over half of physicians are now employed by hospitals and health systems. They change the sign on the door, then offer the same health care services at the same location, but charge more. On average, when a doctor’s office is acquired by a hospital system, prices increase by 14.1%.

On top of these higher prices, hospital systems can also charge additional “facility fees.” Even though the office may be nowhere close to the hospital, patients can get a higher bill. Remember the patient getting a routine ultrasound? Their price increases from $164 to $339 when the hospital sends them to an outpatient clinic. With other routine procedures, like biopsies, the price can skyrocket from $146 to $791, and the price for just a general office visit increases from $118 to $186.

As doctors, we know that these increased costs don’t mean increased quality of care. An MRI or a checkup at an office owned by a hospital isn’t any better than one owned by a physician. It just costs more.

The good news is that Congress has a unique opportunity to tackle this problem with site-neutral payment reforms.

The Lower Costs, More Transparency Act would take on the anti-competitive and predatory behavior of hospital monopolies that is leading to higher health care costs and affordability issues for my patients. This legislation would require all hospitals to publicly disclose the underlying price of procedures, services, and medications, as well as tackle the site-specific payment discrepancies that cost my patients. By doing so, it would reduce government spending and save taxpayers billions of dollars.

The U.S. House of Representatives passed the Lower Costs, More Transparency Act in December of 2023. Now, as leaders in Congress negotiate health care spending legislation ahead of the March 8 deadline, they have an opportunity to include the site-neutral payment provisions of the Lower Costs, More Transparency Act in their package.

This is a true bipartisan issue. Reducing these unfair payment discrepancies is common sense. Congress has an opportunity–and an obligation–to save American patients and taxpayers money by advancing site-neutral payment reform. For the sake of my patients, I hope they’ll seize this opportunity to ensure that the same health care service costs the same.

Rob Davidson, M.D., is the executive director of the Committee to Protect Health Care and a West Michigan Emergency Room physician.

More must-read commentary published by Fortune:

  • Here’s how the U.S., Europe, and China are faring in the post-pandemic race for economic growth
  • Global trade is at a critical juncture–and we can’t take it for granted, WTO meeting chair warns
  • Boeing is shaking up its ‘good ole boys’ culture–but the company still has a long way to go before it gets its production and financials right
  • The anti-DEI movement has gone from fringe to mainstream. Here’s what that means for corporate America

The opinions expressed in Fortune.com commentary pieces are solely the views of their authors and do not necessarily reflect the opinions and beliefs of Fortune.

Fortune Brainstorm AI returns to San Francisco Dec. 8–9 to convene the smartest people we know—technologists, entrepreneurs, Fortune Global 500 executives, investors, policymakers, and the brilliant minds in between—to explore and interrogate the most pressing questions about AI at another pivotal moment. Register here.
About the Author
By Rob Davidson
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.